A pharmacoeconomic analysis of sertindole in the treatment of schizophrenia

We conduct a comparative cost-effectiveness and budget impact analysis of atypical antipsychotics for the treatment of schizophrenia - sertindole versus quetiapine, paliperidone. The primary outcome of interest was rehospitalization rates. The cost of the annual treatment of patients with schizophre...

Full description

Bibliographic Details
Main Authors: I. S. Krysanov, V. Yu. Ermakova
Format: Article
Language:Russian
Published: Izdatelstvo OKI 2018-05-01
Series:Качественная клиническая практика
Subjects:
Online Access:https://www.clinvest.ru/jour/article/view/64
_version_ 1827318126262353920
author I. S. Krysanov
V. Yu. Ermakova
author_facet I. S. Krysanov
V. Yu. Ermakova
author_sort I. S. Krysanov
collection DOAJ
description We conduct a comparative cost-effectiveness and budget impact analysis of atypical antipsychotics for the treatment of schizophrenia - sertindole versus quetiapine, paliperidone. The primary outcome of interest was rehospitalization rates. The cost of the annual treatment of patients with schizophrenia in the outpatient setting was calculated, costs of hospital readmission and total costs.
first_indexed 2024-04-24T23:52:27Z
format Article
id doaj.art-e4fde0a539904510a5f718bca6f53393
institution Directory Open Access Journal
issn 2588-0519
2618-8473
language Russian
last_indexed 2024-04-24T23:52:27Z
publishDate 2018-05-01
publisher Izdatelstvo OKI
record_format Article
series Качественная клиническая практика
spelling doaj.art-e4fde0a539904510a5f718bca6f533932024-03-14T18:09:03ZrusIzdatelstvo OKIКачественная клиническая практика2588-05192618-84732018-05-0104273464A pharmacoeconomic analysis of sertindole in the treatment of schizophreniaI. S. Krysanov0V. Yu. Ermakova1ГБОУ ВПО Медицинский институт усовершенствования врачей МГУППГБОУ ВПО Первый московский государственный медицинский университет им. И.М. СеченоваWe conduct a comparative cost-effectiveness and budget impact analysis of atypical antipsychotics for the treatment of schizophrenia - sertindole versus quetiapine, paliperidone. The primary outcome of interest was rehospitalization rates. The cost of the annual treatment of patients with schizophrenia in the outpatient setting was calculated, costs of hospital readmission and total costs.https://www.clinvest.ru/jour/article/view/64фармакоэкономический анализанализ затраты-эффективностьанализ влияния на бюджетатипичные антипсихотикишизофрениясертиндолчастота повторных госпитализацийpharmacoeconomics analysiscost-effectiveness analysisbudget impact analysisatypical antipsychoticsschizophreniasertindolerehospitalization rate
spellingShingle I. S. Krysanov
V. Yu. Ermakova
A pharmacoeconomic analysis of sertindole in the treatment of schizophrenia
Качественная клиническая практика
фармакоэкономический анализ
анализ затраты-эффективность
анализ влияния на бюджет
атипичные антипсихотики
шизофрения
сертиндол
частота повторных госпитализаций
pharmacoeconomics analysis
cost-effectiveness analysis
budget impact analysis
atypical antipsychotics
schizophrenia
sertindole
rehospitalization rate
title A pharmacoeconomic analysis of sertindole in the treatment of schizophrenia
title_full A pharmacoeconomic analysis of sertindole in the treatment of schizophrenia
title_fullStr A pharmacoeconomic analysis of sertindole in the treatment of schizophrenia
title_full_unstemmed A pharmacoeconomic analysis of sertindole in the treatment of schizophrenia
title_short A pharmacoeconomic analysis of sertindole in the treatment of schizophrenia
title_sort pharmacoeconomic analysis of sertindole in the treatment of schizophrenia
topic фармакоэкономический анализ
анализ затраты-эффективность
анализ влияния на бюджет
атипичные антипсихотики
шизофрения
сертиндол
частота повторных госпитализаций
pharmacoeconomics analysis
cost-effectiveness analysis
budget impact analysis
atypical antipsychotics
schizophrenia
sertindole
rehospitalization rate
url https://www.clinvest.ru/jour/article/view/64
work_keys_str_mv AT iskrysanov apharmacoeconomicanalysisofsertindoleinthetreatmentofschizophrenia
AT vyuermakova apharmacoeconomicanalysisofsertindoleinthetreatmentofschizophrenia
AT iskrysanov pharmacoeconomicanalysisofsertindoleinthetreatmentofschizophrenia
AT vyuermakova pharmacoeconomicanalysisofsertindoleinthetreatmentofschizophrenia